v3.25.2
Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows from Operating Activities    
Net Loss $ (3,617,086) $ (4,403,182)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 433,803 533,667
Stock-based compensation expense 226,053 834,469
Warrants issued for underwriting fee 95,984
Impairment of capitalized software 90,869
Forfeiture of accrued director compensation (200,000)
Changes in operating assets and liabilities which used cash:    
Accounts receivable 23,719 (15,060)
Prepaid expenses and other current assets 309,389 (296,810)
Accounts payable (23,494) (21,163)
Accrued compensation 209,813 590,775
Deferred revenue 36,745 (53,958)
Other accrued liabilities (41,043) 17,483
Net cash and cash equivalents used in operating activities (2,455,248) (2,813,779)
Cash Flows from Investing Activities    
Purchase of property and equipment (1,166)
Investment in capitalized software (378,300) (374,700)
Net cash and cash equivalents used in investing activities (378,300) (375,866)
Cash flows from Financing Activities    
Proceeds from the sale of common stock 3,095,950
Net cash and cash equivalents provided by financing activity 3,095,950
Net increase (decrease) in cash, cash equivalents, and restricted cash 262,402 (3,189,645)
Cash, cash equivalents, and restricted cash - Beginning of year 2,171,016 5,360,661
Cash, cash equivalents, and restricted cash - End of year 2,433,418 2,171,016
Supplemental schedule of non-cash financing activities:    
Settlement of restricted stock units through common stock issuance to directors 399,975
Issuance of common stock for accrued director compensation 21,890
Issuance of common stock for public offering consulting expenses $ 655,000